Ian Shakil - Apr 15, 2024 Form 4 Insider Report for Augmedix, Inc. (AUGX)

Signature
/s/ Todd Holvick, Attorney-in-Fact
Stock symbol
AUGX
Transactions as of
Apr 15, 2024
Transactions value $
-$1,470
Form type
4
Date filed
4/16/2024, 09:07 PM
Previous filing
Apr 15, 2024
Next filing
Aug 19, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUGX Common Stock Options Exercise $430 +500 +16.67% $0.86 3.5K Apr 15, 2024 Direct F1
transaction AUGX Common Stock Sale -$1.9K -500 -14.29% $3.80 3K Apr 15, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUGX Stock Option (Right to Buy) Options Exercise $0 -500 -0.11% $0.00 456K Apr 15, 2024 Common Stock 500 $0.86 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan.
F2 Fully vested.